Alan Davis, an adjunct assistant professor of psychiatry and behavioral sciences at the Johns Hopkins University School of Medicine, stated in a news release that “the magnitude of the effect we saw was about four times larger than what clinical trials have shown for traditional antidepressants on the market.”
If these results are confirmed in future ‘gold-standard’ placebo-controlled trials. It might be a game changer because most existing depression. Therapies take weeks or months to work and may have side effects.controlled
Angermayer is one of the leaders behind the push to legalize long-rejected psychoactive drugs. Notably the psilocybin extracted from so-called magic mushrooms.

He now has a net worth of about $400 million acquired via numerous businesses.